Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hybrid Effectiveness-Implementation Trial for ART Adherence and Substance Use in HIV Care in South Africa

NCT03529409 is registered in ClinicalTrials.gov with University of Maryland, College Park as lead sponsor.

NCT NCT03529409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03529409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hybrid Effectiveness-Implementation Trial for ART Adherence and Substance Use in HIV Care in South Africa
Lead sponsor
University of Maryland, College Park
Phase
Not applicable
Overall status
Completed
Start date
July 30, 2018
Completion date
April 7, 2020
Enrollment
66 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol-related disorders, drug use, human immunodeficiency virus